Detalles de la búsqueda
1.
Determining the maximum tolerated dose of paclitaxel combined with fixed dose of cisplatin for hyperthermic intraperitoneal chemotherapy in ovarian cancer: A multicenter phase I trial.
Gynecol Oncol
; 181: 125-132, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38159362
2.
Real-world experience of postoperative adjuvant chemoimmunotherapy in patients with perihilar cholangiocarcinoma at high risk of recurrence.
Cancer Immunol Immunother
; 72(6): 1753-1761, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36648557
3.
Effects of neoadjuvant hyperthermic intraperitoneal chemotherapy on chemotherapy response score and recurrence in high-grade serous ovarian cancer patients with advanced disease: A multicentre retrospective cohort study.
BJOG
; 129 Suppl 2: 5-13, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36485072
4.
Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.
BMC Cancer
; 17(1): 134, 2017 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28202000
5.
Teaching practice and experiences of verifying the three laws of genetics based on the SSLP marker analysis.
Yi Chuan
; 39(9): 856-862, 2017 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28936983
6.
A phase I dose-finding trial of hyperthermic intraperitoneal docetaxel combined with cisplatin in patients with advanced-stage ovarian cancer.
J Gynecol Oncol
; 35(1): e1, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37477105
7.
Camrelizumab and apatinib plus induction chemotherapy and concurrent chemoradiotherapy in stage N3 nasopharyngeal carcinoma: a phase 2 clinical trial.
Nat Commun
; 15(1): 1029, 2024 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38310101
8.
Efficacy and safety of sintilimab plus bevacizumab in metastatic nasopharyngeal carcinoma after failure of platinum-based chemotherapy: an open-label phase 2 study.
EClinicalMedicine
; 62: 102136, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37593221
9.
Effect of Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone on Progression-Free Survival Among Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma Who Had Received Induction Chemotherapy: A Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 8(4): 553-561, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35175316
10.
Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 8(5): 706-714, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35323856
11.
Efficacy of neoadjuvant hyperthermic intraperitoneal chemotherapy in advanced high-grade serous ovarian cancer (the NHIPEC trial): study protocol for a randomised controlled trial.
BMJ Open
; 11(12): e046415, 2021 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34916306
12.
A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer.
Clin Cancer Res
; 27(15): 4186-4194, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34083231
13.
Stage-specific concurrent chemoradiotherapy with or without induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective, population-based study.
Cancer Manag Res
; 11: 9813-9827, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31819619
14.
Decreased macrophage inflammatory protein (MIP)-1α and MIP-1ß increase the risk of developing nasopharyngeal carcinoma.
Cancer Commun (Lond)
; 38(1): 7, 2018 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29764502
15.
The plasma Epstein-Barr virus DNA level guides precision treatment for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a large population-based cohort study from an endemic area.
Ther Adv Med Oncol
; 10: 1758835918782331, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30046357
16.
Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis.
Cancer Commun (Lond)
; 38(1): 21, 2018 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29764487
17.
Concurrent Chemoradiotherapy versus Intensity-modulated Radiotherapy Alone for Elderly Nasopharyngeal Carcinoma Patients with Pre-treatment Epstein-Barr Virus DNA: A Cohort Study in an Endemic Area with Long-term Follow-up.
J Cancer
; 9(17): 3023-3031, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30210624
18.
Combining cetuximab with chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: A propensity score analysis.
Oral Oncol
; 67: 167-174, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28351572
19.
Evaluation of seven recombinant VCA-IgA ELISA kits for the diagnosis of nasopharyngeal carcinoma in China: a case-control trial.
BMJ Open
; 7(6): e013211, 2017 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28674124
20.
Survival impact of waiting time for radical radiotherapy in nasopharyngeal carcinoma: A large institution-based cohort study from an endemic area.
Eur J Cancer
; 73: 48-60, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28161498